Professor Michael Johnson
The use of computational biology and systems genetics to identify cell-type specific causal pathways and novel drug targets for human brain disease and behaviour.
Professor Michael Johnson is Professor of Neurology and Genomic Medicine in the Department of Brain Sciences at Imperial College London. Clinically active in neurology with a particular focus on the autoimmune and tumour-associated epilepsies.
Professor Johnson is an Honorary Consultant Neurologist at Imperial College Healthcare NHS Trust and a Fellow of the Royal College of Physicians (FRCP), Fellow of the Royal Australasian College of Physicians (FRACP), Fellow of the Royal Society of Medicine (RSM), Member of the UK Association of British Neurologists (ABN), Member of the British Medical Association (BMA) and Member of the International League Against Epilepsy (ILAE). In 2021, Professor Johnson co-founded Cosyne Therapeutics, for which he now acts as an advisor.
